Biotech Values

[floblu14]

December 7, 2009
09:11 EDT TEVA, MNTA theflyonthewall.com: Momenta Pharma may be able to create Copaxone equivalent, says Leerink
According to Leerink Swann, court documents indicate that Teva handed over manufacturing information about Copaxone years ago to a Momenta (MNTA) partner. As a result, the firm thinks that Momenta will be able to more easily create a product that is pharmaceutically equivalent to Copaxone but is not covered by Teva's (TEVA) patent. The firm reiterates an Outperform on Momenta. :theflyonthewall.com

http://www.theflyonthewall.com/permalinks/entry.php/MNTA;TEVAid1172043